NU SKIN ENTERPRISES INC - A (NUS) Fundamental Analysis & Valuation

NYSE:NUS • US67018T1051

7.31 USD
-0.06 (-0.81%)
At close: Mar 11, 2026
7.31 USD
0 (0%)
After Hours: 3/11/2026, 8:16:03 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This NUS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

6

Taking everything into account, NUS scores 6 out of 10 in our fundamental rating. NUS was compared to 37 industry peers in the Personal Care Products industry. NUS has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. NUS scores decently on growth, while it is valued quite cheap. This could make an interesting combination. With these ratings, NUS could be worth investigating further for value investing!.


Dividend Valuation Growth Profitability Health

7

1. NUS Profitability Analysis

1.1 Basic Checks

  • In the past year NUS was profitable.
  • NUS had a positive operating cash flow in the past year.
  • NUS had positive earnings in 4 of the past 5 years.
  • NUS had a positive operating cash flow in each of the past 5 years.
NUS Yearly Net Income VS EBIT VS OCF VS FCFNUS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M 300M

1.2 Ratios

  • The Return On Assets of NUS (11.40%) is better than 83.78% of its industry peers.
  • Looking at the Return On Equity, with a value of 19.90%, NUS belongs to the top of the industry, outperforming 89.19% of the companies in the same industry.
  • NUS has a Return On Invested Capital of 6.50%. This is in the better half of the industry: NUS outperforms 62.16% of its industry peers.
  • NUS had an Average Return On Invested Capital over the past 3 years of 4.60%. This is significantly below the industry average of 11.32%.
  • The 3 year average ROIC (4.60%) for NUS is below the current ROIC(6.50%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 11.4%
ROE 19.9%
ROIC 6.5%
ROA(3y)0.63%
ROA(5y)3.08%
ROE(3y)-0.52%
ROE(5y)5.25%
ROIC(3y)4.6%
ROIC(5y)7.93%
NUS Yearly ROA, ROE, ROICNUS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 -20

1.3 Margins

  • The Profit Margin of NUS (10.79%) is better than 86.49% of its industry peers.
  • In the last couple of years the Profit Margin of NUS has grown nicely.
  • NUS has a Operating Margin of 6.12%. This is in the better half of the industry: NUS outperforms 62.16% of its industry peers.
  • NUS's Operating Margin has declined in the last couple of years.
  • NUS has a Gross Margin (69.45%) which is in line with its industry peers.
  • In the last couple of years the Gross Margin of NUS has remained more or less at the same level.
Industry RankSector Rank
OM 6.12%
PM (TTM) 10.79%
GM 69.45%
OM growth 3Y-5.09%
OM growth 5Y-9.32%
PM growth 3Y31.83%
PM growth 5Y7.79%
GM growth 3Y-1.04%
GM growth 5Y-1.4%
NUS Yearly Profit, Operating, Gross MarginsNUS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. NUS Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NUS is destroying value.
  • The number of shares outstanding for NUS has been reduced compared to 1 year ago.
  • Compared to 5 years ago, NUS has less shares outstanding
  • The debt/assets ratio for NUS has been reduced compared to a year ago.
NUS Yearly Shares OutstandingNUS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
NUS Yearly Total Debt VS Total AssetsNUS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • NUS has an Altman-Z score of 3.72. This indicates that NUS is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of NUS (3.72) is better than 81.08% of its industry peers.
  • The Debt to FCF ratio of NUS is 4.87, which is a neutral value as it means it would take NUS, 4.87 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of NUS (4.87) is better than 70.27% of its industry peers.
  • A Debt/Equity ratio of 0.25 indicates that NUS is not too dependend on debt financing.
  • NUS has a Debt to Equity ratio (0.25) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 4.87
Altman-Z 3.72
ROIC/WACC0.92
WACC7.09%
NUS Yearly LT Debt VS Equity VS FCFNUS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.3 Liquidity

  • NUS has a Current Ratio of 2.08. This indicates that NUS is financially healthy and has no problem in meeting its short term obligations.
  • With a Current ratio value of 2.08, NUS perfoms like the industry average, outperforming 45.95% of the companies in the same industry.
  • NUS has a Quick Ratio of 1.40. This is a normal value and indicates that NUS is financially healthy and should not expect problems in meeting its short term obligations.
  • NUS has a Quick ratio (1.40) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 2.08
Quick Ratio 1.4
NUS Yearly Current Assets VS Current LiabilitesNUS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. NUS Growth Analysis

3.1 Past

  • NUS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 51.76%, which is quite impressive.
  • The earnings per share for NUS have been decreasing by -18.78% on average. This is quite bad
  • Looking at the last year, NUS shows a very negative growth in Revenue. The Revenue has decreased by -14.26% in the last year.
  • NUS shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -10.47% yearly.
EPS 1Y (TTM)51.76%
EPS 3Y-23.58%
EPS 5Y-18.78%
EPS Q2Q%-23.68%
Revenue 1Y (TTM)-14.26%
Revenue growth 3Y-12.62%
Revenue growth 5Y-10.47%
Sales Q2Q%-16.89%

3.2 Future

  • NUS is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 1.27% yearly.
  • Based on estimates for the next years, NUS will show a small growth in Revenue. The Revenue will grow by 1.05% on average per year.
EPS Next Y-21.71%
EPS Next 2Y1.27%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-4.69%
Revenue Next 2Y1.05%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NUS Yearly Revenue VS EstimatesNUS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B 2.5B
NUS Yearly EPS VS EstimatesNUS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

8

4. NUS Valuation Analysis

4.1 Price/Earnings Ratio

  • NUS is valuated cheaply with a Price/Earnings ratio of 5.67.
  • Based on the Price/Earnings ratio, NUS is valued cheaper than 94.59% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 26.15. NUS is valued rather cheaply when compared to this.
  • The Price/Forward Earnings ratio is 7.24, which indicates a rather cheap valuation of NUS.
  • 91.89% of the companies in the same industry are more expensive than NUS, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.27, NUS is valued rather cheaply.
Industry RankSector Rank
PE 5.67
Fwd PE 7.24
NUS Price Earnings VS Forward Price EarningsNUS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NUS indicates a rather cheap valuation: NUS is cheaper than 100.00% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, NUS is valued cheaply inside the industry as 89.19% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 7.65
EV/EBITDA 2.36
NUS Per share dataNUS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • NUS has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.27%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. NUS Dividend Analysis

5.1 Amount

  • NUS has a Yearly Dividend Yield of 3.13%.
  • In the last 3 months the price of NUS has falen by -31.10%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
  • NUS's Dividend Yield is rather good when compared to the industry average which is at 1.66. NUS pays more dividend than 81.08% of the companies in the same industry.
  • NUS's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 3.13%

5.2 History

  • The dividend of NUS decreases each year by -30.34%.
  • NUS has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-30.34%
Div Incr Years0
Div Non Decr Years0
NUS Yearly Dividends per shareNUS Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • NUS pays out 7.39% of its income as dividend. This is a sustainable payout ratio.
DP7.39%
EPS Next 2Y1.27%
EPS Next 3YN/A
NUS Yearly Income VS Free CF VS DividendNUS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M 300M
NUS Dividend Payout.NUS Dividend Payout, showing the Payout Ratio.NUS Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

NUS Fundamentals: All Metrics, Ratios and Statistics

NU SKIN ENTERPRISES INC - A

NYSE:NUS (3/11/2026, 8:16:03 PM)

After market: 7.31 0 (0%)

7.31

-0.06 (-0.81%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)02-12
Earnings (Next)05-06
Inst Owners77.81%
Inst Owner Change1.2%
Ins Owners2.96%
Ins Owner Change5.46%
Market Cap351.83M
Revenue(TTM)1.49B
Net Income(TTM)160.20M
Analysts45
Price TargetN/A
Short Float %4.26%
Short Ratio3.9
Dividend
Industry RankSector Rank
Dividend Yield 3.13%
Yearly Dividend0.24
Dividend Growth(5Y)-30.34%
DP7.39%
Div Incr Years0
Div Non Decr Years0
Ex-Date02-27
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.96%
Min EPS beat(2)-4.29%
Max EPS beat(2)12.21%
EPS beat(4)3
Avg EPS beat(4)38.88%
Min EPS beat(4)-4.29%
Max EPS beat(4)73.83%
EPS beat(8)6
Avg EPS beat(8)39.66%
EPS beat(12)9
Avg EPS beat(12)28.85%
EPS beat(16)12
Avg EPS beat(16)23.55%
Revenue beat(2)0
Avg Revenue beat(2)-3.91%
Min Revenue beat(2)-4.19%
Max Revenue beat(2)-3.63%
Revenue beat(4)2
Avg Revenue beat(4)-0.96%
Min Revenue beat(4)-4.19%
Max Revenue beat(4)2.51%
Revenue beat(8)4
Avg Revenue beat(8)-1.07%
Revenue beat(12)5
Avg Revenue beat(12)-1.25%
Revenue beat(16)6
Avg Revenue beat(16)-1.69%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-44.44%
EPS NQ rev (3m)-44.44%
EPS NY rev (1m)-29.58%
EPS NY rev (3m)-29.58%
Revenue NQ rev (1m)-7.59%
Revenue NQ rev (3m)-7.59%
Revenue NY rev (1m)-6.67%
Revenue NY rev (3m)-6.67%
Valuation
Industry RankSector Rank
PE 5.67
Fwd PE 7.24
P/S 0.24
P/FCF 7.65
P/OCF 4.38
P/B 0.44
P/tB 0.52
EV/EBITDA 2.36
EPS(TTM)1.29
EY17.65%
EPS(NY)1.01
Fwd EY13.82%
FCF(TTM)0.96
FCFY13.08%
OCF(TTM)1.67
OCFY22.82%
SpS30.86
BVpS16.73
TBVpS14.11
PEG (NY)N/A
PEG (5Y)N/A
Graham Number22.04
Profitability
Industry RankSector Rank
ROA 11.4%
ROE 19.9%
ROCE 7.96%
ROIC 6.5%
ROICexc 8.23%
ROICexgc 9.57%
OM 6.12%
PM (TTM) 10.79%
GM 69.45%
FCFM 3.1%
ROA(3y)0.63%
ROA(5y)3.08%
ROE(3y)-0.52%
ROE(5y)5.25%
ROIC(3y)4.6%
ROIC(5y)7.93%
ROICexc(3y)5.71%
ROICexc(5y)10.2%
ROICexgc(3y)7.03%
ROICexgc(5y)13.41%
ROCE(3y)5.63%
ROCE(5y)9.71%
ROICexgc growth 3Y-12.47%
ROICexgc growth 5Y-21.24%
ROICexc growth 3Y-9.16%
ROICexc growth 5Y-17.8%
OM growth 3Y-5.09%
OM growth 5Y-9.32%
PM growth 3Y31.83%
PM growth 5Y7.79%
GM growth 3Y-1.04%
GM growth 5Y-1.4%
F-Score7
Asset Turnover1.06
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 4.87
Debt/EBITDA 1.43
Cap/Depr 65.59%
Cap/Sales 2.31%
Interest Coverage 5.44
Cash Conversion 56.09%
Profit Quality 28.72%
Current Ratio 2.08
Quick Ratio 1.4
Altman-Z 3.72
F-Score7
WACC7.09%
ROIC/WACC0.92
Cap/Depr(3y)69.21%
Cap/Depr(5y)75.81%
Cap/Sales(3y)2.56%
Cap/Sales(5y)2.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)51.76%
EPS 3Y-23.58%
EPS 5Y-18.78%
EPS Q2Q%-23.68%
EPS Next Y-21.71%
EPS Next 2Y1.27%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-14.26%
Revenue growth 3Y-12.62%
Revenue growth 5Y-10.47%
Sales Q2Q%-16.89%
Revenue Next Year-4.69%
Revenue Next 2Y1.05%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y78.98%
EBIT growth 3Y-17.06%
EBIT growth 5Y-18.81%
EBIT Next Year130.74%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-34.42%
FCF growth 3Y-2.08%
FCF growth 5Y-31.95%
OCF growth 1Y-28.15%
OCF growth 3Y-9.44%
OCF growth 5Y-26.69%

NU SKIN ENTERPRISES INC - A / NUS FAQ

Can you provide the ChartMill fundamental rating for NU SKIN ENTERPRISES INC - A?

ChartMill assigns a fundamental rating of 6 / 10 to NUS.


What is the valuation status of NU SKIN ENTERPRISES INC - A (NUS) stock?

ChartMill assigns a valuation rating of 8 / 10 to NU SKIN ENTERPRISES INC - A (NUS). This can be considered as Undervalued.


How profitable is NU SKIN ENTERPRISES INC - A (NUS) stock?

NU SKIN ENTERPRISES INC - A (NUS) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for NUS stock?

The Price/Earnings (PE) ratio for NU SKIN ENTERPRISES INC - A (NUS) is 5.67 and the Price/Book (PB) ratio is 0.44.


Can you provide the dividend sustainability for NUS stock?

The dividend rating of NU SKIN ENTERPRISES INC - A (NUS) is 5 / 10 and the dividend payout ratio is 7.39%.